IBDEI0LZ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10760,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,10761,0)
 ;;=294.8^^64^689^33
 ;;^UTILITY(U,$J,358.3,10761,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10761,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,10761,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,10761,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,10762,0)
 ;;=438.6^^64^689^7
 ;;^UTILITY(U,$J,358.3,10762,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10762,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,10762,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,10762,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,10763,0)
 ;;=438.7^^64^689^26
 ;;^UTILITY(U,$J,358.3,10763,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10763,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,10763,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,10763,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,10764,0)
 ;;=438.84^^64^689^5
 ;;^UTILITY(U,$J,358.3,10764,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10764,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,10764,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,10764,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,10765,0)
 ;;=434.91^^64^689^27
 ;;^UTILITY(U,$J,358.3,10765,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10765,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,10765,1,5,0)
 ;;=5^CVA, Acute Onset
 ;;^UTILITY(U,$J,358.3,10765,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,10766,0)
 ;;=333.94^^64^689^101
 ;;^UTILITY(U,$J,358.3,10766,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10766,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,10766,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,10766,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,10767,0)
 ;;=345.90^^64^689^104
 ;;^UTILITY(U,$J,358.3,10767,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10767,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,10767,1,5,0)
 ;;=5^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,10767,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,10768,0)
 ;;=907.0^^64^689^73
 ;;^UTILITY(U,$J,358.3,10768,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10768,1,4,0)
 ;;=4^907.0
 ;;^UTILITY(U,$J,358.3,10768,1,5,0)
 ;;=5^Late Effect Intracranial Injury
 ;;^UTILITY(U,$J,358.3,10768,2)
 ;;=^68489
 ;;^UTILITY(U,$J,358.3,10769,0)
 ;;=339.00^^64^689^43
 ;;^UTILITY(U,$J,358.3,10769,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10769,1,4,0)
 ;;=4^339.00
 ;;^UTILITY(U,$J,358.3,10769,1,5,0)
 ;;=5^Headache,Cluster NOS
 ;;^UTILITY(U,$J,358.3,10769,2)
 ;;=^336741
 ;;^UTILITY(U,$J,358.3,10770,0)
 ;;=339.01^^64^689^42
 ;;^UTILITY(U,$J,358.3,10770,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10770,1,4,0)
 ;;=4^339.01
 ;;^UTILITY(U,$J,358.3,10770,1,5,0)
 ;;=5^Headache,Cluster Episodic
 ;;^UTILITY(U,$J,358.3,10770,2)
 ;;=^336545
 ;;^UTILITY(U,$J,358.3,10771,0)
 ;;=339.02^^64^689^41
 ;;^UTILITY(U,$J,358.3,10771,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10771,1,4,0)
 ;;=4^339.02
 ;;^UTILITY(U,$J,358.3,10771,1,5,0)
 ;;=5^Headache,Cluster Chronic
 ;;^UTILITY(U,$J,358.3,10771,2)
 ;;=^336546
 ;;^UTILITY(U,$J,358.3,10772,0)
 ;;=339.03^^64^689^65
 ;;^UTILITY(U,$J,358.3,10772,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10772,1,4,0)
 ;;=4^339.03
 ;;^UTILITY(U,$J,358.3,10772,1,5,0)
 ;;=5^Hemicrania,Paroxysmal,Episodic
 ;;^UTILITY(U,$J,358.3,10772,2)
 ;;=^336547
 ;;^UTILITY(U,$J,358.3,10773,0)
 ;;=339.04^^64^689^64
 ;;^UTILITY(U,$J,358.3,10773,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10773,1,4,0)
 ;;=4^339.04
 ;;^UTILITY(U,$J,358.3,10773,1,5,0)
 ;;=5^Hemicrania,Paroxysmal,Chr
